Highlights

• Torrent Pharmaceuticals shares rose nearly 3 percent during Thursday's session.
• The stock is trading close to its 52-week high of INR 4,712.90.
• Torrent Pharma has outperformed the NIFTY Next 50 across major periods.

Shares of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) gained 3.11 percent on June 11, 2026, with the stock trading at INR 4,597.30.

The stock opened at INR 4,471.60 and climbed to an intraday high of INR 4,604.70 before easing slightly. The day's low was INR 4,431.10, while the volume-weighted average price (VWAP) stood at INR 4,555.71. The move kept the pharmaceutical stock close to its 52-week high of INR 4,712.90 recorded on May 25, 2026.

Stock Trades Near Record Levels

Torrent Pharmaceuticals has witnessed a sustained uptrend over the past year. The stock is currently trading less than 3 percent below its 52-week high and significantly above its 52-week low of INR 3,140.10 recorded on June 23, 2025.

The recovery from the annual low highlights the strong price appreciation seen in the stock over the last 12 months. Market participants have closely tracked developments in the pharmaceutical sector, including product portfolios, domestic formulations business and international market opportunities. At the current price, Torrent Pharmaceuticals remains among the larger listed pharmaceutical companies by market capitalisation.

Outperformance Across Time Horizons

The stock has consistently outperformed the NIFTY Next 50 index across multiple periods. Over the past week, Torrent Pharmaceuticals delivered returns of 6.03 percent, while the NIFTY Next 50 declined 1.82 percent. During the last month, the stock gained 1.87 percent compared with a 2.22 percent decline in the benchmark index.

On a year-to-date basis, Torrent Pharmaceuticals advanced 19.57 percent, substantially ahead of the benchmark's decline of 1.35 percent. The one-year return stood at 43.54 percent against a near-flat return of negative 0.05 percent for the NIFTY Next 50. The longer-term performance remains notable, with the stock generating returns of 154.80 percent over three years and 219.57 percent over five years.

Source: NSE

Trading Activity Remains Healthy

Torrent Pharmaceuticals recorded traded volume of 4.58 lakh shares, translating into traded value of INR 208.89 crore during the session.

The company had a total market capitalisation of INR 1.56 lakh crore, while free-float market capitalisation stood at INR 47,980.90 crore. Deliverable quantity accounted for 52.15 percent of traded volume, indicating a significant share of delivery-based transactions.

The stock's impact cost was reported at 0.03, reflecting liquidity and trading efficiency.

Valuation and Volatility Metrics

Exchange data indicates that Torrent Pharmaceuticals' price-to-earnings ratio remains above 50 based on the previous four trailing quarters. Such valuation levels often place greater attention on earnings growth, operational performance and future business developments.

The stock reported daily volatility of 1.37 percent and annualised volatility of 26.17 percent. Compared with several mid-cap and small-cap stocks, Torrent Pharmaceuticals has exhibited relatively lower volatility despite generating substantial long-term returns.

The stock currently trades without fixed circuit limits, allowing prices to move freely based on market conditions.

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited is one of India's pharmaceutical companies engaged in the research, development, manufacturing and marketing of generic pharmaceutical formulations.

The company serves domestic and international markets across multiple therapeutic segments. Torrent Pharmaceuticals is the flagship company of the Torrent Group, which also has interests in power generation and city gas distribution businesses.

Key Risks

• Regulatory actions can impact pharmaceutical product approvals.
• Currency fluctuations may affect international business performance.
• High valuation levels may increase earnings sensitivity.
• Competitive pressures remain significant in generic pharmaceuticals.

Share Performance Today

Torrent Pharmaceuticals shares traded at INR 4,602.40 on June 11, 2026, up 3.11 percent from the previous close of INR 4,463.70. The stock touched an intraday high of INR 4,604.70 and a low of INR 4,431.10. Traded volume stood at 4.58 lakh shares, while traded value reached INR 208.89 crore.

    Source: TradingView

Summary

Torrent Pharmaceuticals (NSE:TORNTPHARM) remained in focus after gaining nearly 3 percent on June 11, 2026. The stock is trading close to its 52-week high of INR 4,712.90 and has delivered returns of 43.54 percent over the past year. With a market capitalisation exceeding INR 1.55 lakh crore and long-term returns significantly outperforming the NIFTY Next 50, the company continues to be closely watched within the pharmaceutical sector.

FAQs

Q: How much did Torrent Pharmaceuticals shares gain today?
A: The stock rose 3.11 percent to INR 4,602.40 during the June 11, 2026 session.

Q: What is the 52-week high of Torrent Pharmaceuticals shares?
A: The stock's 52-week high is INR 4,712.90, recorded on May 25, 2026.

Q: How has Torrent Pharmaceuticals performed over the last year?
A: The stock has delivered a one-year return of 43.54 percent.